DENTSPLY SIRONA Inc (NASDAQ: XRAY) has reported a loss for its second fiscal quarter (ending June 30) of $-0.02 versus $0.41 for the same period a year ago. For the latest four quarters through June 30, E.P.S. were $-0.86 versus $-4.77 for the same period a year ago.
Recent Price Action
DENTSPLY SIRONA Inc (NASDAQ: XRAY) stock closed at $27.14 on 7/31/24 after an increase of 1.3%. Moreover, this advance was accompanied by unusually high trading volume at 184% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 4.1% during the last week.
Current PriceTarget Research Rating
XRAY’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be an important Value Builder.
DENTSPLY SIRONA has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. DENTSPLY SIRONA has a neutral Appreciation Score of 40 but a very low Power Rating of 13, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment